A tale of two trials: selectively replicating herpesviruses for brain tumors

被引：12

作者：

Kim, DH ^{[1
]}

机构：

[1] Hammersmith Hosp, ICSTM, Imperial Canc Res Fund, Viral & Genet Therapy Programme, London W12 0NN, England

来源：

GENE THERAPY | 2000年 / 7卷 / 10期

关键词：

D O I：

10.1038/sj.gt.3301213

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：815 / 816

页数：2

共 11 条

[1] Reovirus therapy of tumors with activated Ras pathway [J].

Coffey, MC ;

Strong, JE ;

Forsyth, PA ;

Lee, PWK .

SCIENCE, 1998, 282 (5392) :1332-1334

[2] A novel three-pronged approach to kill cancer cells selectively: Concomitant viral, double suicide gene, and radiotherapy [J].

Freytag, SO ;

Rogulski, KR ;

Paielli, DL ;

Gilbert, JD ;

Kim, JH .

HUMAN GENE THERAPY, 1998, 9 (09) :1323-1333

[3] ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents [J].

Heise, C ;

SampsonJohannes, A ;

Williams, A ;

McCormick, F ;

VonHoff, DD ;

Kirn, DH .

NATURE MEDICINE, 1997, 3 (06) :639-645

[4]

KIRN D, 1998, P AN M AM SOC CLIN, V17, pA391

[5] Replication-selective microbiological agents: fighting cancer with targeted germ warfare [J].

Kirn, DH .

JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (07) :837-839

[6]

KIRN DH, 1999, P AN M AM SOC CLIN, V18, P1505

[7] Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial [J].

Markert, JM ;

Medlock, MD ;

Rabkin, SD ;

Gillespie, GY ;

Todo, T ;

Hunter, WD ;

Palmer, CA ;

Feigenbaum, F ;

Tornatore, C ;

Tufaro, F ;

Martuza, RL .

GENE THERAPY, 2000, 7 (10) :867-874

[8] ATTENUATED MULTI-MUTATED HERPES-SIMPLEX VIRUS-1 FOR THE TREATMENT OF MALIGNANT GLIOMAS [J].

MINETA, T ;

RABKIN, SD ;

YAZAKI, T ;

HUNTER, WD ;

MARTUZA, RL .

NATURE MEDICINE, 1995, 1 (09) :938-943

[9]

Pawelek JM, 1997, CANCER RES, V57, P4537

[10] Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma [J].

Rampling, R ;

Cruickshank, G ;

Papanastassiou, V ;

Nicoll, J ;

Hadley, D ;

Brennan, D ;

Petty, R ;

MacLean, A ;

Harland, J ;

McKie, E ;

Mabbs, R ;

Brown, M .

GENE THERAPY, 2000, 7 (10) :859-866

← 1 2 →